These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 21978426

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S, Katzenstein AL.
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [Abstract] [Full Text] [Related]

  • 3. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.
    Terry J, Leung S, Laskin J, Leslie KO, Gown AM, Ionescu DN.
    Am J Surg Pathol; 2010 Dec; 34(12):1805-11. PubMed ID: 21107086
    [Abstract] [Full Text] [Related]

  • 4. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ, Shin HC, Shin KC, Ro JY.
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [Abstract] [Full Text] [Related]

  • 5. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
    Loo PS, Thomas SC, Nicolson MC, Fyfe MN, Kerr KM.
    J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168
    [Abstract] [Full Text] [Related]

  • 6. Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases.
    Gurda GT, Zhang L, Wang Y, Chen L, Geddes S, Cho WC, Askin F, Gabrielson E, Li QK.
    Clin Transl Med; 2015 Apr; 4():16. PubMed ID: 25977750
    [Abstract] [Full Text] [Related]

  • 7. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
    Koh J, Go H, Kim MY, Jeon YK, Chung JH, Chung DH.
    Histopathology; 2014 Dec; 65(6):868-78. PubMed ID: 25130792
    [Abstract] [Full Text] [Related]

  • 8. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
    Nishino M, Hoang MP, Della Pelle P, Morales-Oyarvide V, Huynh TG, Mark EJ, Mino-Kenudson M.
    Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
    [Abstract] [Full Text] [Related]

  • 9. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
    Khayyata S, Yun S, Pasha T, Jian B, McGrath C, Yu G, Gupta P, Baloch Z.
    Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
    Au NH, Cheang M, Huntsman DG, Yorida E, Coldman A, Elliott WM, Bebb G, Flint J, English J, Gilks CB, Grimes HL.
    J Pathol; 2004 Sep; 204(1):101-9. PubMed ID: 15307143
    [Abstract] [Full Text] [Related]

  • 11. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
    Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH.
    Clin Cancer Res; 2010 Jan 15; 16(2):610-9. PubMed ID: 20068099
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
    Aikawa E, Kawahara A, Hattori S, Yamaguchi T, Abe H, Taira T, Azuma K, Kage M.
    Cancer Cytopathol; 2011 Oct 25; 119(5):335-45. PubMed ID: 21717589
    [Abstract] [Full Text] [Related]

  • 13. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.
    Rossi G, Marchioni A, Milani M, Scotti R, Foroni M, Cesinaro A, Longo L, Migaldi M, Cavazza A.
    Am J Clin Pathol; 2004 Dec 25; 122(6):884-93. PubMed ID: 15595193
    [Abstract] [Full Text] [Related]

  • 14. The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
    van Zyl A, Schubert PT, Koegelenberg CFN.
    Cytopathology; 2019 Nov 25; 30(6):586-591. PubMed ID: 31206846
    [Abstract] [Full Text] [Related]

  • 15. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.
    Tsuta K, Tanabe Y, Yoshida A, Takahashi F, Maeshima AM, Asamura H, Tsuda H.
    J Thorac Oncol; 2011 Jul 25; 6(7):1190-9. PubMed ID: 21623236
    [Abstract] [Full Text] [Related]

  • 16. A study of ΔNp63 expression in lung non-small cell carcinomas.
    Nonaka D.
    Am J Surg Pathol; 2012 Jun 25; 36(6):895-9. PubMed ID: 22367298
    [Abstract] [Full Text] [Related]

  • 17. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
    Sharma R, Wang Y, Chen L, Gurda GT, Geddes S, Gabrielson E, Askin F, Li QK.
    Hum Pathol; 2016 Aug 25; 54():8-16. PubMed ID: 27045515
    [Abstract] [Full Text] [Related]

  • 18. The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment.
    Ma Y, Fan M, Dai L, Kang X, Liu Y, Sun Y, Yan W, Liang Z, Xiong H, Chen K.
    Tumour Biol; 2015 Sep 25; 36(10):8085-92. PubMed ID: 25982999
    [Abstract] [Full Text] [Related]

  • 19. The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.
    Ao MH, Zhang H, Sakowski L, Sharma R, Illei PB, Gabrielson E, Askin F, Li QK.
    Hum Pathol; 2014 May 25; 45(5):926-34. PubMed ID: 24746197
    [Abstract] [Full Text] [Related]

  • 20. Accuracy of classifying poorly differentiated non-small cell lung carcinoma biopsies with commonly used lung carcinoma markers.
    Zachara-Szczakowski S, Verdun T, Churg A.
    Hum Pathol; 2015 May 25; 46(5):776-82. PubMed ID: 25776027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.